ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,54
-2,74%
Bitcoin
57 764,88
-4,68%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. AbSci Corporation (ABSI)

  7. AbSci Corporation (ABSI) Actualités

ABSI AbSci Corporation

5,152
0,412 (8,69%)
Après les heures de négociation
Dernière mise à jour : 00:32:33
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
AbSci Corporation ABSI NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,412 8,69% 5,152 00:32:33
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,86 4,805 5,37 5,19 4,74
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/4/202414:00GLOBEAbsci to Report Business Updates and First Quarter 2024..
28/3/202421:05GLOBEAbsci to Participate in the 23rd Annual Needham Virtual..
21/3/202412:30GLOBEAbsci Reports Business Updates and Fourth Quarter and Full..
01/3/202422:01GLOBEAbsci Announces Closing of Public Offering of Common Stock..
28/2/202422:06EDGAR2Form 8-K - Current report
28/2/202414:34EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/2/202404:20GLOBEAbsci Announces Pricing of Public Offering of Common Stock
27/2/202422:45EDGAR2Form 8-K - Current report
27/2/202422:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/2/202422:01GLOBEAbsci Announces Proposed Public Offering of Common Stock
21/2/202413:30GLOBEAbsci Initiates IND-Enabling Studies for ABS-101, a..
20/2/202414:00GLOBEAbsci to Participate in Upcoming Investor Conferences
14/2/202400:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202401:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202413:30GLOBEAbsci Appoints Professor Sir Mene Pangalos to its Board of..
08/1/202413:08EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEAbsci to Present Preclinical Data for ABS-101, A Potential..
04/1/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/1/202414:00GLOBEAbsci to Participate in the 26th Annual Needham Growth..
28/12/202314:00GLOBEAbsci to Participate in the 42nd Annual J.P. Morgan..
20/12/202314:30EDGAR2Form 8-K - Current report
20/12/202313:30GLOBEAbsci and PrecisionLife Announce Strategic R&D Partnership..
07/12/202314:30EDGAR2Form 8-K - Current report
04/12/202316:41DJNAbsci Shares Rise 27% After Announcing Collaboration With..
04/12/202313:31EDGAR2Form 8-K - Current report
04/12/202313:30GLOBEAbsci Announces Collaboration with AstraZeneca to Advance..
15/11/202314:00GLOBEAbsci to Participate in the Piper Sandler 35th Annual..
14/11/202322:40EDGAR2Form 8-K - Current report
14/11/202322:05GLOBEAbsci Reports Business Updates and Third Quarter 2023..
14/11/202308:16BWAlmirall and Absci announce AI drug discovery partnership to..
14/11/202308:05GLOBEAlmirall and Absci announce AI drug discovery partnership to..
26/10/202314:00GLOBEAbsci to Participate in Upcoming Investor Conferences
17/10/202300:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202300:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202300:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202300:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202314:00GLOBEAbsci Announces Speaker Lineup for Inaugural R&D Day,..
06/9/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202314:00GLOBEAbsci to Host R&D Day on October 4, 2023
05/9/202314:15EDGAR2Form 8-K - Current report
28/8/202322:05GLOBEAbsci to Participate in Upcoming Investor Conferences
17/8/202323:02EDGAR2Form 8-K - Current report
14/8/202314:13EDGAR2Form 8-K - Current report
14/8/202314:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202314:02GLOBEAbsci Reports Business Updates and Second Quarter 2023..
14/8/202314:00GLOBEAbsci Appoints Zach Jonasson, Ph.D., as Chief Financial..

Dernières Valeurs Consultées

NASDAQ
ABSI
AbSci
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés